Advertisement

Persistent analgesia in former opiate addicts is resistant to blockade of endogenous opioids

      This paper is only available as a PDF. To read, Please Download here.

      Key Words

      References

        • Bandura A
        • Cioffi D
        • Taylor CB
        • Brouillard ME
        Perceived self-efficacy in coping with cognitive stressors and opioid activation.
        J Pers Soc Psychol. 1988; 55: 479-488
        • Bozarth M
        • Wise RA
        Anatomically distinct opiate receptor fields mediate reward and physical dependence.
        Science. 1984; 224: 516-517
        • Buchsbaum MS
        • Davis GC
        • Bunney Jr, WE
        Naloxone alters pain perception and somatosensory evoked potentials in normal subjects.
        Nature. 1977; 270: 620-622
        • Dole VP
        • Nyswander M
        Heroin addiction—A metabolic disease.
        Arch Intern Med. 1967; 120: 19-24
        • Grisel JE
        • Fleshner M
        • Watkins LR
        • Maier SF
        Opioid and nonopioid interactions in two forms of stress-induced analgesia.
        Pharmacol Biochem Behav. 1993; 45: 161-172
        • Jensen TS
        Endogenous antinociceptive systems: Studies on spinal and supraspinal modulating mechanisms with particular reference to monoaminergic and opioid systems.
        Acta Neurol Scand Suppl. 1986; 108: 1-35
        • Jungkunz G
        • Engel RR
        • King UG
        • Kuss HJ
        Endogenous opiates increase pain tolerance after stress in humans.
        Psychiatry Res. 1983; 8: 13-18
        • Kirchgessner AL
        • Bodnar J
        • Pasternak GW
        Naloxazone and pain-inhibitory systems: Evidence for a collateral inhibition model.
        Pharmacol Biochem Behav. 1982; 17: 1175-1179
        • Lehofer M
        • Liebmann PM
        • Moser M
        • Legl T
        • Pernhaupt G
        • Schauenstein K
        • et al.
        Decreased nociceptive sensitivity: A biological risk marker for opiate dependence?.
        Addiction. 1997; 92: 163-166
      1. Lehofer M, Liebmann PM, Moser M, Schauenstein K, Zapotoczky HG (in press): Nervousness and pain sensitivity: I. A positive correlation. Psychiatry Res.

        • Liebmann PM
        • Lehofer M
        • Schönauer-Cejpek M
        • Legl T
        • Pernhaupt G
        • Moser M
        • et al.
        Pain sensitivity in former opioid addicts.
        Lancet. 1994; 344: 1031-1032
      2. Liebmann PM, Lehofer M, Moser M, Hoehn-Saric R, Legl T, Pernhaupt G, et al (in press): Nervousness and pain sensitivity: II. Changed relation in ex-addicts as a predictor for early relapse. Psychiatry Res.

        • Lipp J
        Possible mechanisms of morphine analgesia.
        Clin Neuropharmacol. 1991; 14: 131-147
        • Maldonado R
        • Koob GF
        Destruction of the locus coeruleus decreases physical signs of opiate withdrawal.
        Brain Res. 1993; 605: 128-138
        • Martin WR
        • Jasinski DR
        • Mansky PA
        • Lexington K
        Naltrexone, an antagonist for the treatment of heroin dependence.
        Arch Gen Psychiatry. 1973; 28: 784-791
        • Resnick RB
        • Volavka J
        • Freedman AM
        Studies on EN-1639 (naltrexone) a new narcotic antagonist.
        Am J Psychiatry. 1974; 131: 646-650
        • Turk DC
        • Meichenbaum D
        • Genest M
        Pain and Behavioral Medicine: A Cognitive-Behavioral Perspective.
        in: Guilford, 1983: 452
        • Watkins LR
        • Mayer DL
        Organization of endogenous opiate and nonopiate pain control systems.
        Science. 1982; 216: 1185-1192
        • Yoburn BC
        • Truesdell LS
        • Kest B
        • Inturrisi CE
        • Bodnar RJ
        Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia.
        Pharmacol Biochem Behav. 1987; 27: 525-527